LFVN logo

LIFEVANTAGE CORP

LFVNNASDAQ
πŸ† #4229 by market capEarnings Nov 2US Equity
$6.29β–² $0.05 (+0.72%)
After hours Β· at close
πŸ””
Track LFVN
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 0.7%
7dβ–² 1.5%
14dβ–Ό 0.5%
30dβ–Ό 4.7%
ytdβ–² 1.6%
1yβ–Ό 35.4%
🏦Market Cap
$79M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-20.1%
Declining
πŸ“ŠGross Margin
77.6%
High
πŸ’΅FCF Margin
3.6%
Moderate
βš–οΈP/S Ratio
0.4x
Cheap
Otter Score
92
Very Good

Trading Snapshot

Day Range
$6.21 – $6.39
52-Week Range
$3.90 – $11.71
Volume
$2.42B
Avg Volume
$1.72B
Shares Outstanding
12.6M
Next Earnings
Dec 2, 2026

Fundamentals Snapshot

Annual Revenue
$183M
Last Q Revenue
$42M
P/E Ratio
15.5
P/S Ratio
0.4x
EPS (TTM)
$0.40
Dividend Yield
3.07%
Dilution (1yr)
βˆ’0.3%

Why Investors Own LFVN

  • βœ“High-growth profile β€” revenue up +38.3% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 58% gross margin and 23% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

LFVN logo

LIFEVANTAGE CORP

LFVN
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$183Mβ–Ό βˆ’20.1% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
77.6%β–Ό βˆ’3.5% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$6Mβ–Ό βˆ’50.0% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$7Mβ–Ό βˆ’36.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
12.7Mβ–Ό βˆ’0.3% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$5Mβ–² +$6M YoY
StockOtter Β· stockotter.space

About LIFEVANTAGE CORP

LifeVantage Corporation (LFVN) specializes in the development, manufacture, and distribution of a diverse portfolio of health, wellness, and personal care products. Its offerings encompass nutrigenomic activators (designed to influence genetic expression), a broad array of dietary supplements, cognitive enhancers (nootropics), gut health support (pre- and pro-biotics), weight management solutions, and various personal care items spanning skin care, hair care, bath and body, and targeted relief. The company's product lineup features well-known brands such as Protandim, a series of scientifically validated dietary supplements. Specific examples include LifeVantage Omega+, a blend of DHA/EPA Omega-3s, Omega-7s, and Vitamin D3; LifeVantage ProBio, designed for digestive wellness; the PhysIQ brand for weight management; Petandim, tailored to reduce oxidative stress in dogs; and Axio energy drink mixes. Under the TrueScience brand, LifeVantage also provides anti-aging skincare (e.g., facial cleansers, perfecting lotions, eye serums, creams), hair care solutions (e.g., invigorating shampoos, nourishing conditioners, scalp serums), and an assortment of bath and body products (e.g., body lotion, wash, butter, deodorant) and targeted relief items (e.g., soothing balm, body rub). Distribution occurs through both its proprietary website and an extensive network of independent distributors. LifeVantage maintains a significant international presence, with operations spanning numerous global territories including the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. The corporation's headquarters are situated in Lehi, Utah.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Very Good
92/100

Analyst Ratings

β“˜
Consensus
Buy
8 analysts
Strong Buy2
Buy4
Hold2
Sell0
Strong Sell0
Ratings as of Sep 2026

Latest News & Updates